PP_1170x120_10-25-21

insulin prices

PCMA: ADA report confirms drugmakers set to raise insulin prices

PCMA: ADA report confirms drugmakers set to raise insulin prices

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) released the following statement regarding a white paper released today by the American Diabetes Association on insulin prices: “The American Diabetes Association’s new white paper on insulin prices confirms that drugmakers set, and continue to raise, prices. Along with high prices for insulin products, drug manufacturer product